Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
07 2019
Historique:
received: 15 12 2017
revised: 09 06 2018
accepted: 07 07 2018
pubmed: 14 9 2018
medline: 7 3 2020
entrez: 14 9 2018
Statut: ppublish

Résumé

To estimate the prevalence and causes of blindness and vision impairment for distance and near in Latin America and the Caribbean (LAC) in 2015 and to forecast trends to 2020. A meta-analysis from a global systematic review of 283 cross-sectional, population-representative studies from published and unpublished sources from 1980 to 2014 in the Global Vision Database included 17 published and 6 unpublished studies from LAC. In 2015, across LAC, age-standardised prevalence was 0.38% in all ages and 1.56% in those over age 50 for blindness; 2.06% in all ages and 7.86% in those over age 50 for moderate and severe vision impairment (MSVI); 1.89% in all ages and 6.93% in those over age 50 for mild vision impairment and 39.59% in all ages and 45.27% in those over 50 for near vision impairment (NVI). In 2015, 117.86 million persons were vision impaired; of those 2.34 million blind, 12.46 million with MSVI, 11.34 million mildly impaired and 91.72 million had NVI. Cataract is the most common cause of blindness. Undercorrected refractive-error is the most common cause of vision impairment. These prevalence estimates indicate that one in five persons across LAC had some degree of vision loss in 2015. We predict that from 2015 to 2020, the absolute numbers of persons with vision loss will increase by 12% to 132.33 million, while the all-age age-standardised prevalence will decrease for blindness by 15% and for other distance vision impairment by 8%. All countries need epidemiologic research to establish accurate national estimates and trends. Universal eye health services must be included in universal health coverage reforms to address disparities, fragmentation and segmentation of healthcare.

Identifiants

pubmed: 30209083
pii: bjophthalmol-2017-311746
doi: 10.1136/bjophthalmol-2017-311746
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

885-893

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Janet L Leasher (JL)

College of Optometry, Nova Southeastern University, Fort Lauderdale, Florida, USA.

Tasanee Braithwaite (T)

Moorfields Eye Hospital, London, UK.

João M Furtado (JM)

Division of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Seth R Flaxman (SR)

Department of Mathematics and Data Science Institute, Imperial College London, London, UK.

Van Charles Lansingh (VC)

HelpMeSee, Inc, New York City, New York, USA.
Instituto Mexicano de Oftalmología, Querétaro, Mexico.

Juan Carlos Silva (JC)

Pan American Health Organization, Bogotá, Colombia.

Serge Resnikoff (S)

Brien Holden Vision Institute & School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.

Hugh R Taylor (HR)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Rupert R A Bourne (RRA)

Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK rb@rupertbourne.co.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH